Discover how this breakthrough technology can deliver fast, accurate biophysical characterization. Join our Mass Photometry 101 webinar to learn the basics, explore diverse applications, and see how it can accelerate your research. […]
In this webinar, we will show how we used mass photometry, a single molecule imaging technique capable of detecting biomolecular complexes in solution, to characterize ivonescimab’s binding behaviour with VEGF […]
This session will highlight new research focused on optimizing AAV6 upstream production – an essential step in improving the safety and affordability of gene therapies. Using a design of experiment […]
Antibodies remain at the heart of modern therapeutics and diagnostics and the technologies driving their discovery are evolving rapidly. In this webinar, we’ll explore the latest innovations in antibody screening, […]
Join us for a webinar to learn how advances in purification techniques have enhanced AAV sample compatibility with mass photometry in upstream development, delivering real-time insights for improved process control […]
Join me to discover how integrating mass photometry into antibody development workflows can drive rapid reliable decision-making. Mass photometry enhances antibody development workflows with insights from: Column-free aggregation assessment in […]
We will present quantitative results from inhibitor binding studies using mass photometry. Attendees will find out how to implement mass photometry-based workflows for rapid assessment of RNA integrity, enabling faster […]
This webinar explores the latest advancements and persistent challenges in AAV-based gene therapy, focusing on analytical testing and manufacturing control. Dr. Anthony Blaszczyk introduces the first USP AAV reference materials, […]
In this webinar, we demonstrate how the mass of AAV capsids can be determined using two different novel, emerging single-particle techniques: Charge-detection mass spectrometry (CDMS) and mass photometry. In contrast […]
Adeno-associated viruses (AAVs) play a crucial role in gene therapy, but producing high-quality vectors at scale remains challenging, particularly due to inefficiencies in DNA packaging. This results in a high […]
